In glioma cell lines KCa3.1 expression level correlates with cell invasiveness in response to the chemokine CXCL12, serum, and bradykinin (Sciaccaluga et al., 2010; Catacuzzeno et al., 2011; Cuddapah et al., 2013). The gene discussed is CXCL12; the disease is central nervous system cancer.